2022
DOI: 10.1016/j.genrep.2022.101676
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic aspect of microRNA inhibition in various types of hypertension and hypertensive complications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
1
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
1
1
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 68 publications
0
1
0
1
Order By: Relevance
“…MicroRNA (miRNA) is a non-coding small fragment (approximately 20–22 nucleotides) single-stranded RNA molecule participating in various physiological processes in cells. , MiRNA let-7 is one of the earliest discovered miRNA families with 13 members in humans of which the miRNA let-7a is the earliest identified oncogene fragment . Numerous pathological studies have shown that the abnormal expression of miRNA let-7a in tumor cells and serum is correlated to many cancers, such as hepatocellular carcinoma (HCC), breast cancer, and pancreatic cancer, making miRNA let-7a one of crucial cancer biomarkers.…”
Section: Introductionmentioning
confidence: 99%
“…MicroRNA (miRNA) is a non-coding small fragment (approximately 20–22 nucleotides) single-stranded RNA molecule participating in various physiological processes in cells. , MiRNA let-7 is one of the earliest discovered miRNA families with 13 members in humans of which the miRNA let-7a is the earliest identified oncogene fragment . Numerous pathological studies have shown that the abnormal expression of miRNA let-7a in tumor cells and serum is correlated to many cancers, such as hepatocellular carcinoma (HCC), breast cancer, and pancreatic cancer, making miRNA let-7a one of crucial cancer biomarkers.…”
Section: Introductionmentioning
confidence: 99%
“…A hipertensão é uma das principais causas de doenças cardiovasculares e renais, e prevê-se que até 2025, cerca de 25% dos adultos em todo mundo serão hipertensos (PREETHI et al, 2022). Apesar da ampla variedade de medicamentos anti-hipertensivos, apenas 21% dos indivíduos submetidos a essa terapia farmacológica terão a pressão arterial devidamente controlada (LOBO, ADEYEYE, KAPIL., 2022).…”
Section: Introductionunclassified